Insights from the AUSTRI study on reliever use before and after asthma exacerbations

J Allergy Clin Immunol Pract. 2022 Jul;10(7):1916-1918.e2. doi: 10.1016/j.jaip.2022.03.029. Epub 2022 Apr 9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma* / drug therapy
  • Asthma* / epidemiology
  • Bronchodilator Agents / therapeutic use
  • Budesonide / therapeutic use
  • Ethanolamines / therapeutic use
  • Formoterol Fumarate / therapeutic use
  • Humans

Substances

  • Anti-Asthmatic Agents
  • Bronchodilator Agents
  • Ethanolamines
  • Budesonide
  • Formoterol Fumarate

Associated data

  • ClinicalTrials.gov/NCT01475721